Clinical trial
Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in…
NCT00407186 · Dutch Colorectal Cancer Group, Other · Unknown status
Key facts
| NCT number | NCT00407186 |
|---|---|
| Title | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) |
| Official title | A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study) |
| Lead sponsor | Dutch Colorectal Cancer Group, Other |
| Collaborators | The Netherlands Cancer Institute Roche Pharma AG Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine |
| Enrollment | 788 |
| Start date | Jan 11, 2007 |
| Primary completion | Dec 1, 2018 |
| Completion | Dec 1, 2025 |
| First posted | Dec 4, 2006 |
| Last update posted | Oct 10, 2017 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: